Trichomonas Vaginalis Flavin Reductase 1 and Its Role in Metronidazole Resistance

Overview

Journal Mol Microbiol

Specialties Microbiology
Molecular Biology

Date 2013 Nov 22

PMID 24256032

Citations 31

Authors

David Leitsch

Brian D Janssen

Daniel Kolarich

Patricia J Johnson

Michael Duchene

Affiliations

Soon will be listed here.

Abstract

The enzyme flavin reductase 1 (FR1) from Trichomonas vaginalis, formerly known as NADPH oxidase, was isolated and identified. Flavin reductase is part of the antioxidative defence in T. vaginalis and indirectly reduces molecular oxygen to hydrogen peroxide via free flavins. Importantly, a reduced or absent flavin reductase activity has been reported in metronidazole-resistant T. vaginalis, resulting in elevated intracellular oxygen levels and futile cycling of metronidazole. Interestingly, FR1 has no close homologue in any other sequenced genome, but seven full-length and three truncated isoforms exist in the T. vaginalis genome. However, out of these, only FR1 has an affinity for flavins, i.e. FMN, FAD and riboflavin, which is high enough to be of physiological relevance. Although there are no relevant changes in the gene sequence or any alterations of the predicted FR1-mRNA structure in any of the strains studied, FR1 is not expressed in highly metronidazole-resistant strains. Transfection of a metronidazole-resistant clinical isolate (B7268), which does not express any detectable amounts of FR, with a plasmid bearing a functional FR1 gene nearly completely restored metronidazole sensitivity. Our results indicate that FR1 has a significant role in the emergence of metronidazole resistance in T. vaginalis.

Citing Articles

Roles of efflux pumps and nitroreductases in metronidazole-resistant Trichomonas vaginalis.

Paunkov A, Strasser D, Huber P, Leitsch D Parasitol Res. 2025; 124(2):21.

PMID: 39937247 PMC: 11821713. DOI: 10.1007/s00436-025-08463-7.

Culturing of Giardia lamblia under microaerobic conditions can impact metronidazole susceptibility by inducing increased expression of antioxidant enzymes.

Starynets K, Paunkov A, Wagner A, Kratochwill K, Klotz C, Leitsch D Int J Parasitol Drugs Drug Resist. 2025; 27:100585.

PMID: 39904006 PMC: 11847123. DOI: 10.1016/j.ijpddr.2025.100585.

Targeting histone acetylation to overcome drug resistance in the parasite .

Seifert-Gorzycki J, Munoz D, Lizarraga A, Iriarte L, Coceres V, Strobl-Mazzulla P bioRxiv. 2025; .

PMID: 39829914 PMC: 11741363. DOI: 10.1101/2025.01.07.631743.

Imidazole Carbamates as a Promising Alternative for Treating Trichomoniasis: In Vitro Effects on the Growth and Gene Expression of .

Martinez-Rosas V, Navarrete-Vazquez G, Ortega-Cuellar D, Arreguin-Espinosa R, la Cruz V, Calderon-Jaimes E Molecules. 2024; 29(11).

PMID: 38893461 PMC: 11173628. DOI: 10.3390/molecules29112585.

Effect of Trichomonacide 6-Nitro-1-benzimidazole Derivative Compounds on Expression Level of Metabolic Genes in .

Gutierrez-Cardona J, Calderon-Jaimes E, Ortega-Cuellar D, Sanchez-Carrillo A, Castillo-Rodriguez R, Canseco-Avila L Int J Mol Sci. 2024; 25(8).

PMID: 38674152 PMC: 11050703. DOI: 10.3390/ijms25084568.

References

Carlton J, Hirt R, Silva J, Delcher A, Schatz M, Zhao Q . Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science. 2007; 315(5809):207-12. PMC: 2080659. DOI: 10.1126/science.1132894. View

Yarlett N, Yarlett N, Lloyd D . Metronidazole-resistant clinical isolates of Trichomonas vaginalis have lowered oxygen affinities. Mol Biochem Parasitol. 1986; 19(2):111-6. DOI: 10.1016/0166-6851(86)90115-5. View

Williams C, Lloyd D, Kolarich D, Alagesan K, Duchene M, Cable J . Disrupted intracellular redox balance of the diplomonad fish parasite Spironucleus vortens by 5-nitroimidazoles and garlic-derived compounds. Vet Parasitol. 2012; 190(1-2):62-73. DOI: 10.1016/j.vetpar.2012.05.011. View

Petrin D, Delgaty K, Bhatt R, Garber G . Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev. 1998; 11(2):300-17. PMC: 106834. DOI: 10.1128/CMR.11.2.300. View

Moreno S, Docampo R . Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis. Environ Health Perspect. 1985; 64:199-208. PMC: 1568619. DOI: 10.1289/ehp.8564199. View

Mason R, Holtzman J . The role of catalytic superoxide formation in the O2 inhibition of nitroreductase. Biochem Biophys Res Commun. 1975; 67(4):1267-74. DOI: 10.1016/0006-291x(75)90163-1. View

Kulda J . Trichomonads, hydrogenosomes and drug resistance. Int J Parasitol. 1999; 29(2):199-212. DOI: 10.1016/s0020-7519(98)00155-6. View

Yarlett N, Gorrell T, Marczak R, Muller M . Reduction of nitroimidazole derivatives by hydrogenosomal extracts of Trichomonas vaginalis. Mol Biochem Parasitol. 1985; 14(1):29-40. DOI: 10.1016/0166-6851(85)90103-3. View

Goldman L, Upcroft J, Workowski K, Rapkin A . Treatment of metronidazole-resistant Trichomonas vaginalis. Sex Health. 2009; 6(4):345-7. DOI: 10.1071/SH09064. View

10.

Tanabe M . Trichomonas vaginalis: NADH oxidase activity. Exp Parasitol. 1979; 48(1):135-43. DOI: 10.1016/0014-4894(79)90063-8. View

11.

Schwebke J, Barrientes F . Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother. 2006; 50(12):4209-10. PMC: 1693974. DOI: 10.1128/AAC.00814-06. View

12.

Sobel J, Nyirjesy P, Brown W . Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis. 2001; 33(8):1341-6. DOI: 10.1086/323034. View

13.

Coombs G, Westrop G, Suchan P, Puzova G, Hirt R, Embley T . The amitochondriate eukaryote Trichomonas vaginalis contains a divergent thioredoxin-linked peroxiredoxin antioxidant system. J Biol Chem. 2003; 279(7):5249-56. DOI: 10.1074/jbc.M304359200. View

14.

Delgadillo M, Liston D, Niazi K, Johnson P . Transient and selectable transformation of the parasitic protist Trichomonas vaginalis. Proc Natl Acad Sci U S A. 1997; 94(9):4716-20. PMC: 20790. DOI: 10.1073/pnas.94.9.4716. View

15.

Yarlett N, Yarlett N, Lloyd D . Ferredoxin-dependent reduction of nitroimidazole derivatives in drug-resistant and susceptible strains of Trichomonas vaginalis. Biochem Pharmacol. 1986; 35(10):1703-8. DOI: 10.1016/0006-2952(86)90327-8. View

16.

Meingassner J, THURNER J . Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob Agents Chemother. 1979; 15(2):254-7. PMC: 352642. DOI: 10.1128/AAC.15.2.254. View

17.

Chapman A, Cammack R, Linstead D, Lloyd D . The generation of metronidazole radicals in hydrogenosomes isolated from Trichomonas vaginalis. J Gen Microbiol. 1985; 131(9):2141-4. DOI: 10.1099/00221287-131-9-2141. View

18.

Linstead D, Bradley S . The purification and properties of two soluble reduced nicotinamide: acceptor oxidoreductases from Trichomonas vaginalis. Mol Biochem Parasitol. 1988; 27(2-3):125-33. DOI: 10.1016/0166-6851(88)90032-1. View

19.

Kulda J, Tachezy J, Cerkasovova A . In vitro induced anaerobic resistance to metronidazole in Trichomonas vaginalis. J Eukaryot Microbiol. 1993; 40(3):262-9. DOI: 10.1111/j.1550-7408.1993.tb04915.x. View

20.

Ellis J, Wingfield J, Cole D, Boreham P, Lloyd D . Oxygen affinities of metronidazole-resistant and -sensitive stocks of Giardia intestinalis. Int J Parasitol. 1993; 23(1):35-9. DOI: 10.1016/0020-7519(93)90095-g. View